BRYAN BURT to Antineoplastic Agents
This is a "connection" page, showing publications BRYAN BURT has written about Antineoplastic Agents.
Connection Strength
0.650
-
A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. J Thorac Oncol. 2018 09; 13(9):1400-1409.
Score: 0.280
-
CTLA4 blockade in patients with malignant mesothelioma. Lancet Respir Med. 2015 Apr; 3(4):261-3.
Score: 0.225
-
Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science. 2023 09 08; 381(6662):eabn4180.
Score: 0.101
-
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling. Mol Cancer Ther. 2021 08; 20(8):1469-1480.
Score: 0.022
-
Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer. Gut. 2017 02; 66(2):215-225.
Score: 0.015
-
Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207). FASEB J. 2004 Jun; 18(9):1001-3.
Score: 0.007